Advanced
  Home Compare Reports

Comparison with Similar Reports

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Di...

by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals)

Publisher:        MarketsandMarkets

# of Pages:        211

Rating: 

1 User License $4,950

Publication Date:  October, 2020

Price:       $4,950 / User License




TABLE OF CONTENTS

 

1              INTRODUCTION                20

1.1          OBJECTIVES OF THE STUDY          20

1.2          MARKET DEFINITION      21

1.2.1      INCLUSIONS AND EXCLUSIONS  21

1.3          MARKET SCOPE                22

1.3.1      MARKETS COVERED        22

1.3.2      YEARS CONSIDERED FOR THE STUDY        22

1.4          CURRENCY          23

1.5          LIMITATIONS     23

1.6          STAKEHOLDERS 23

1.7          SUMMARY OF CHANGES              24

2              RESEARCH METHODOLOGY         25

2.1          RESEARCH DATA               25

FIGURE 1             RESEARCH DESIGN          25

2.1.1      SECONDARY DATA           25

2.1.1.1   KEY DATA FROM SECONDARY SOURCES 26

2.1.2      PRIMARY DATA 26

FIGURE 2             PRIMARY SOURCES         26

2.1.2.1   KEY DATA FROM PRIMARY SOURCES       27

2.1.2.2   BREAKDOWN OF PRIMARY SOURCES      28

FIGURE 3             BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION,

AND REGION     28

2.2          MARKET SIZE ESTIMATION          28

FIGURE 4             MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS  29

FIGURE 5             ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)          29

FIGURE 6             SUPPLY-SIDE ANALYSIS: DIGITAL PATHOLOGY MARKET (2019)    30

FIGURE 7             BOTTOM-UP APPROACH              31

FIGURE 8             CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS      32

FIGURE 9             CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE DIGITAL PATHOLOGY MARKET (2020-2025)  32

2.3          MARKET BREAKDOWN AND DATA TRIANGULATION        34

FIGURE 10           DATA TRIANGULATION METHODOLOGY               34

2.4          MARKET SHARE ESTIMATION     35

2.5          ASSUMPTIONS FOR THE STUDY 35

2.6          COVID-19 HEALTH ASSESSMENT                36

 

2.7          COVID-19 ECONOMIC ASSESSMENT        36

2.7.1      ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO          36

2.8          ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO PERTAINING TO THE DIGITAL PATHOLOGY MARKET    39

3              EXECUTIVE SUMMARY  40

FIGURE 13           DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)         40

FIGURE 14           DIGITAL PATHOLOGY MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)    41

FIGURE 15           DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2020 VS. 2025 (USD MILLION)     41

FIGURE 16           DIGITAL PATHOLOGY MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)         42

FIGURE 17           GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET           43

4              PREMIUM INSIGHTS       44

4.1          DIGITAL PATHOLOGY MARKET OVERVIEW            44

FIGURE 18           RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH    44

4.2          NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT AND COUNTRY (2019)    45

FIGURE 19           SCANNERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2019    45

4.3          DIGITAL PATHOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES               46

FIGURE 20           UK AND CHINA TO WITNESS THE HIGHEST GROWTH IN THE DIGITAL PATHOLOGY MARKET DURING THE FORECAST PERIOD           46

5              MARKET OVERVIEW       47

5.1          INTRODUCTION                47

5.2          MARKET DYNAMICS       47

TABLE 1                MARKET DYNAMICS: IMPACT ANALYSIS                47

5.2.1      DRIVERS               47

5.2.1.1   INCREASING ADOPTION OF DIGITAL PATHOLOGY TO ENHANCE LAB EFFICIENCY                47

5.2.1.2   RISING PREVALENCE OF CANCER              48

TABLE 2                GLOBAL CANCER INCIDENCE, 2018 VS. 2025         48

5.2.1.3   GROWING APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DEVELOPMENT AND COMPANION DIAGNOSTICS  49

5.2.1.4   INCREASING INITIATIVES BY INDUSTRY PLAYERS               50

5.2.2      RESTRAINTS       50

5.2.2.1   HIGH COST OF DIGITAL PATHOLOGY SYSTEMS    50

5.2.3      OPPORTUNITIES               50

5.2.3.1   INTRODUCTION OF AFFORDABLE SCANNERS FOR PRIVATE PATHOLOGY PRACTICES         50

5.2.3.2   INCREASING DEMAND FOR PERSONALIZED MEDICINE    51

TABLE 3                GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008–2016     51

5.2.3.3   HIGH GROWTH OPPORTUNITIES IN EMERGING ECONOMIES       52

5.2.4      CHALLENGES      52

5.2.4.1   LACK OF TRAINED PATHOLOGISTS            52

TABLE 4                NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018         52

5.3          COVID-19 IMPACT ANALYSIS      53

5.3.1      IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET      53

FIGURE 21           IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET      53

5.4          ECOSYSTEM MARKET MAP          54

FIGURE 22           DIGITAL PATHOLOGY MARKET: ECOSYSTEM MARKET MAP           54

5.5          TRENDS IN AVERAGE SELLING PRICE       55

FIGURE 23           DIGITAL PATHOLOGY MARKET: AVERAGE REGIONAL PRICES OF DIGITAL PATHOLOGY SCANNERS              55

5.6          IMPACT OF THE NEW IVD REGULATION ON DIFFERENT MARKETS              55

FIGURE 24           TIMELINE AND TRANSITION TO NEW MDR AND IVDR      56

5.6.1      IMPACT ON CLINICAL LAB SERVICES        57

5.6.2      IMPACT ON IVD                58

5.6.3      IMPACT ON DIGITAL PATHOLOGY            58

5.7          TECHNOLOGY ANALYSIS               58

5.7.1      AI IN DIGITAL PATHOLOGY          59

TABLE 5                DIGITAL PATHOLOGY AI MARKET, BY REGION, 2018–2025 (USD MILLION)              59

5.8          PATENT ANALYSIS           60

5.8.1      METHODOLOGY               60

5.8.2      PUBLICATION TRENDS   60

FIGURE 25           PUBLICATION TRENDS, 2015–2020           60

5.8.3      JURISDICTION ANALYSIS               60

FIGURE 26           JURISDICTION ANALYSIS, 2015–2020       61

5.8.4      TOP APPLICANTS             61

FIGURE 27           TOP APPLICANTS, 2015–2020      61

6              DIGITAL PATHOLOGY MARKET, BY PRODUCT       62

6.1          INTRODUCTION                63

TABLE 6                DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)               63

6.2          SCANNERS          63

6.2.1      SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PATHOLOGY PRODUCTS MARKET IN 2019       63

TABLE 7                SCANNING MAGNIFICATION AND APPLICATIONS            64

TABLE 8                DIGITAL PATHOLOGY SCANNERS OFFERED BY KEY MARKET PLAYERS        64

TABLE 9                DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           65

TABLE 10              DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION,

2018–2025 (USD MILLION)           65

TABLE 11              DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018–2025 (UNITS)           66

TABLE 12              DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           66

6.2.2      BRIGHTFIELD SCANNERS               66

TABLE 13              DIGITAL PATHOLOGY BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS             66

TABLE 14              BRIGHTFIELD SCANNERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)         67

6.2.3      FLUORESCENCE SCANNERS         67

TABLE 15              DIGITAL PATHOLOGY FLUORESCENCE SCANNERS OFFERED

BY KEY MARKET PLAYERS              67

TABLE 16              FLUORESCENCE SCANNERS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           68

6.2.4      OTHER DIGITAL PATHOLOGY SCANNERS                69

TABLE 17              OTHER DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           69

6.3          SOFTWARE         70

6.3.1      DIGITAL PATHOLOGY SOFTWARE OFFERS ANALYTICAL AND HIGHLY ADVANCED FUNCTIONS NOT OFFERED BY TRADITIONAL MICROSCOPES     70

TABLE 18              DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS       70

TABLE 19              DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           71

TABLE 20              DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           71

6.3.2      INFORMATION MANAGEMENT SOFTWARE         72

TABLE 21              INFORMATION MANAGEMENT SOFTWARE MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           72

6.3.3      IMAGE ANALYSIS SOFTWARE     73

TABLE 22              IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           73

6.3.4      VISUALIZATION SOFTWARE        74

TABLE 23              VISUALIZATION SOFTWARE MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           74

6.4          COMMUNICATION SYSTEMS      75

6.4.1      INTRODUCTION OF CLOUD-BASED COMMUNICATION SYSTEMS PROVIDES IMPETUS TO MARKET GROWTH         75

TABLE 24              COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY         75

TABLE 25              DIGITAL PATHOLOGY COMMUNICATION SYSTEMS OFFERED BY KEY MARKET PLAYERS    76

TABLE 26              DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)    76

6.5          STORAGE SYSTEMS         77

6.5.1      NEED FOR STORING HIGH-QUALITY IMAGES IN A SAFE AND RELIABLE FORM TO DRIVE MARKET GROWTH             77

TABLE 27              DIGITAL PATHOLOGY STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS       78

TABLE 28              DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           78

7              DIGITAL PATHOLOGY MARKET, BY TYPE 79

7.1          INTRODUCTION                80

TABLE 29              DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)          80

7.2          HUMAN PATHOLOGY     80

7.2.1      HUMAN PATHOLOGY SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD                80

TABLE 30              HUMAN DIGITAL PATHOLOGY MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           81

7.3          VETERINARY PATHOLOGY            81

7.3.1      VETERINARY DIGITAL PATHOLOGY CUTS THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS—A KEY FACTOR DRIVING MARKET GROWTH      81

TABLE 31              VETERINARY DIGITAL PATHOLOGY MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           82

8              DIGITAL PATHOLOGY MARKET, BY APPLICATION               83

8.1          INTRODUCTION                84

TABLE 32              DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)        84

8.2          DRUG DISCOVERY            84

8.2.1      INCREASING R&D SPENDING WILL PROVIDE IMPETUS TO MARKET GROWTH       84

TABLE 33              APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY/RESEARCH              84

TABLE 34              DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY,

2018–2025 (USD MILLION)           85

8.3          DISEASE DIAGNOSIS       86

8.3.1      DISEASE DIAGNOSIS SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD 86

TABLE 35              DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2018–2025 (USD MILLION)            87

8.4          TELECONSULTATION      87

8.4.1      THE NEED FOR ACCURATE, EFFICIENT, AND QUICK DIAGNOSIS IS EXPECTED TO DRIVE THE TELECONSULTATION MARKET DURING THE FORECAST PERIOD              87

TABLE 36              DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY,

2018–2025 (USD MILLION)           88

8.5          TRAINING & EDUCATION             89

8.5.1      DIGITAL PATHOLOGY CAN IMPROVE EDUCATION AND TRAINING PROVIDED TO PATHOLOGISTS                89

TABLE 37              DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2018–2025 (USD MILLION)  89

9              DIGITAL PATHOLOGY MARKET, BY END USER      90

9.1          INTRODUCTION                91

TABLE 38              DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)               91

TABLE 39              DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,

2018–2025 (USD MILLION)           91

TABLE 40              DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,

2018–2025 (UNITS)          92

9.2          PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES       92

9.2.1      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF THE DIGITAL PATHOLOGY MARKET   92

TABLE 41              DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)           93

TABLE 42              DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)        93

TABLE 43              DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (UNITS)       94

9.3          HOSPITALS & REFERENCE LABORATORIES             94

9.3.1      INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT                94

TABLE 44              HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS    95

TABLE 45              DIGITAL PATHOLOGY MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION)             96

TABLE 46              DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018–2025 (USD MILLION)       96

TABLE 47              DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018–2025 (UNITS)      97

9.4          ACADEMIC & RESEARCH INSTITUTES       97

9.4.1      ACADEMIC & RESEARCH INSTITUTES SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD 97

TABLE 48              DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES,

BY COUNTRY, 2018–2025 (USD MILLION)               98

TABLE 49              DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 99

TABLE 50              DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (UNITS)                99

10           DIGITAL PATHOLOGY MARKET, BY REGION          100

10.1        INTRODUCTION                101

FIGURE 28           DIGITAL PATHOLOGY MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)             101

TABLE 51              DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)   101

10.2        NORTH AMERICA             102

FIGURE 29           NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT      102

TABLE 52              NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           103

TABLE 53              NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           103

TABLE 54              NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           103

TABLE 55              NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           104

TABLE 56              NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE,

2018–2025 (USD MILLION)           104

TABLE 57              NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           104

TABLE 58              NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           105

TABLE 59              NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (USD MILLION)   105

TABLE 60              NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (UNITS) 105

 

10.2.1    US          106

10.2.1.1                FAVORABLE REIMBURSEMENT SCENARIO FOR DIGITAL PATHOLOGY IN THE US  106

TABLE 61              US: CANCER CASES, 2018              106

TABLE 62              CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US                107

TABLE 63              US: KEY MACROINDICATORS      107

TABLE 64              US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)       108

TABLE 65              US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           108

TABLE 66              US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           108

TABLE 67              US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)  109

TABLE 68              US: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           109

TABLE 69              US: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           109

10.2.2    CANADA              110

10.2.2.1                GROWING NEED FOR HIGH-QUALITY CANCER DIAGNOSIS AND GOVERNMENT INITIATIVES TO DRIVE THE MARKET GROWTH IN CANADA  110

TABLE 70              CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING         111

TABLE 71              CANADA: KEY MACROINDICATORS          111

TABLE 72              CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           112

TABLE 73              CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           112

TABLE 74              CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           112

TABLE 75              CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE,

2018–2025 (USD MILLION)           113

TABLE 76              CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           113

TABLE 77              CANADA: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025(USD MILLION)            113

10.3        EUROPE               114

FIGURE 30           EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT         114

TABLE 78              EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           115

TABLE 79              EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           115

TABLE 80              EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           115

TABLE 81              EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           116

TABLE 82              EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)       116

TABLE 83              EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           116

TABLE 84              EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           117

TABLE 85              EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,

2018–2025 (USD MILLION)           117

TABLE 86              EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,

2018–2025 (UNITS)          117

10.3.1    UK          118

10.3.1.1                THE UK IS THE LARGEST MARKET FOR DIGITAL PATHOLOGY IN EUROPE  118

TABLE 87              CONFERENCES/COURSES HELD/TO BE HELD IN THE UK    119

TABLE 88              UK: KEY MACROINDICATORS      119

TABLE 89              UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)       120

TABLE 90              UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           120

TABLE 91              UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           120

TABLE 92              UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION) 121

TABLE 93              UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           121

TABLE 94              UK: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           121

10.3.2    GERMANY           122

10.3.2.1                HIGH HEALTHCARE EXPENDITURE AND SUPPORTIVE HEALTH INSURANCE TO DRIVE MARKET GROWTH IN GERMANY           122

TABLE 95              GERMANY: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025 122

TABLE 96              GERMANY: KEY MACROINDICATORS       123

TABLE 97              GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           123

TABLE 98              GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           123

TABLE 99              GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           124

TABLE 100            GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE,

2018–2025 (USD MILLION)S         124

TABLE 101            GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           124

TABLE 102            GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           125

10.3.3    SWEDEN              125

10.3.3.1                INCREASING GOVERNMENT INITIATIVES AND DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS            125

TABLE 103            SWEDEN: CANCER CASES, 2018  125

TABLE 104            SWEDEN: KEY MACROINDICATORS          126

TABLE 105            SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025(USD MILLION)            126

TABLE 106            SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           127

TABLE 107            SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           127

TABLE 108            SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE,

2018–2025 (USD MILLION)           127

TABLE 109            SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           128

TABLE 110            SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           128

10.3.4    DENMARK           128

10.3.4.1                HIGH CANCER PREVALENCE TO DRIVE THE MARKET GROWTH IN DENMARK         128

FIGURE 31           DENMARK: CANCER PREVALENCE, 2012–2020     129

TABLE 111            DENMARK: KEY MACROINDICATORS       129

TABLE 112            DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           130

TABLE 113            DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           130

TABLE 114            DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           130

TABLE 115            DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE,

2018–2025 (USD MILLION)           131

TABLE 116            DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           131

TABLE 117            DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           131

10.3.5    FRANCE                132

10.3.5.1                INCREASING INCIDENCE OF CANCER TO DRIVE THE MARKET GROWTH DURING THE FORECAST PERIOD   132

TABLE 118            FRANCE: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025      132

TABLE 119            FRANCE: KEY MACROINDICATORS            132

TABLE 120            FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           133

TABLE 121            FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           133

TABLE 122            FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           133

TABLE 123            FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)       134

TABLE 124            FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           134

TABLE 125            FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           134

10.3.6    REST OF EUROPE (ROE) 135

TABLE 126            ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           135

TABLE 127            ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           135

TABLE 128            ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           136

TABLE 129            ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)               136

TABLE 130            ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           136

TABLE 131            ROE: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           137

10.4        ASIA PACIFIC     137

TABLE 132            ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           137

TABLE 133            ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           138

TABLE 134            ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           138

TABLE 135            ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           138

TABLE 136            ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE,

2018–2025 (USD MILLION)           139

TABLE 137            ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           139

TABLE 138            ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           139

TABLE 139            ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (USD MILLION)           140

TABLE 140            ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018–2025 (UNITS)          140

10.4.1    CHINA   140

10.4.1.1                FAVORABLE INITIATIVES FOR THE ADOPTION OF TELEPATHOLOGY IN CHINA       140

TABLE 141            CHINA: CANCER CASES, 2018      141

TABLE 142            CHINA: KEY MACROINDICATORS               141

TABLE 143            CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           142

TABLE 144            CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           142

TABLE 145            CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           142

TABLE 146            CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)          143

TABLE 147            CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           143

TABLE 148            CHINA: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           143

10.4.2    JAPAN  144

10.4.2.1                INCREASING INITIATIVES BY INDUSTRY PLAYERS FOR CANCER DIAGNOSIS TO DRIVE MARKET GROWTH  144

TABLE 149            JAPAN: KEY MACROINDICATORS              144

TABLE 150            JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           144

TABLE 151            JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           145

TABLE 152            JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           145

TABLE 153            JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)          145

TABLE 154            JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           146

TABLE 155            JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           146

10.4.3    INDIA    146

10.4.3.1                GROWING NUMBER OF CANCER CASES IN INDIA TO DRIVE THE MARKET GROWTH           146

TABLE 156            INDIA: KEY MACROINDICATORS                147

TABLE 157            INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           147

TABLE 158            INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           148

TABLE 159            INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           148

TABLE 160            INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)           148

TABLE 161            INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           149

TABLE 162            INDIA: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           149

10.4.4    REST OF ASIA PACIFIC (ROAPAC)              149

TABLE 163            ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           150

TABLE 164            ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           150

TABLE 165            ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           150

TABLE 166            ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)      151

TABLE 167            ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           151

TABLE 168            ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           151

10.5        REST OF THE WORLD       152

TABLE 169            ROW: DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)      152

TABLE 170            ROW: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           152

TABLE 171            ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           152

TABLE 172            ROW: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           153

TABLE 173            ROW: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)             153

TABLE 174            ROW: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           153

TABLE 175            ROW: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           154

TABLE 176            ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,

2018–2025 (USD MILLION)           154

TABLE 177            ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER,

2018–2025 (UNITS)          154

10.5.1    LATIN AMERICA                155

10.5.1.1                INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY TO DRIVE THE MARKET GROWTH IN LATIN AMERICA                155

TABLE 178            LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           155

TABLE 179            LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           155

TABLE 180            LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE,

2018–2025 (USD MILLION)           156

TABLE 181            LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE,

2018–2025 (USD MILLION)           156

TABLE 182            LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           156

TABLE 183            LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           157

10.5.2    MIDDLE EAST & AFRICA 157

10.5.2.1                INFRASTRUCTURAL DEVELOPMENTS IN THE REGION TO SUPPORT MARKET GROWTH     157

TABLE 184            MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           158

TABLE 185            MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 158

TABLE 186            MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)                158

TABLE 187            MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE,

2018–2025 (USD MILLION)           159

TABLE 188            MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)      159

TABLE 189            MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER,

2018–2025 (USD MILLION)           159

11           COMPETITIVE LANDSCAPE           160

11.1        INTRODUCTION                160

11.2        MARKET EVALUATION FRAMEWORK      160

FIGURE 32           MARKET EVALUATION FRAMEWORK: PARTNERSHIPS AND COLLABORATIONS WERE THE MOST WIDELY ADOPTED STRATEGIES   160

11.3        MARKET SHARE ANALYSIS            161

FIGURE 33           MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019                161

11.4        DIGITAL PATHOLOGY MARKET: GEOGRAPHICAL ASSESSMENT    162

FIGURE 34           GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET (2019)             162

11.5        DIGITAL PATHOLOGY MARKET: R&D EXPENDITURE          162

FIGURE 35           R&D EXPENDITURE OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET (2019)              162

11.6        COMPETITIVE SCENARIO              163

11.6.1    KEY DEVELOPMENTS IN THE DIGITAL PATHOLOGY MARKET          163

TABLE 190            PARTNERSHIPS & COLLABORATIONS (JANUARY 2017–SEPTEMBER 2020)                163

11.6.2    KEY PRODUCT LAUNCHES             163

TABLE 191            PRODUCT LAUNCHES (JANUARY 2017–SEPTEMBER 2020)              163

11.6.3    KEY EXPANSIONS             164

TABLE 192            EXPANSIONS (JANUARY 2017–SEPTEMBER 2020)              164

12           COMPANY EVALUATION MATRIX & COMPANY PROFILES              165

12.1        COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY              165

12.2        COMPANY EVALUATION MATRIX             165

12.2.1    STARS   165

12.2.2    EMERGING LEADERS      165

12.2.3    PERVASIVE         165

12.2.4    PARTICIPANTS  166

FIGURE 36           DIGITAL PATHOLOGY MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019      166

12.3        COMPETITIVE LEADERSHIP MAPPING: STARTUPS/SMES                167

12.3.1    PROGRESSIVE COMPANIES         167

12.3.2    STARTING BLOCKS           167

12.3.3    RESPONSIVE COMPANIES            167

12.3.4    DYNAMIC COMPANIES  167

FIGURE 37           COMPETITIVE LEADERSHIP MAPPING OF THE DIGITAL PATHOLOGY MARKET: STARTUPS/SMES   168

12.4        COMPANY PROFILES      169

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW)*

12.4.1    LEICA BIOSYSTEMS          169

FIGURE 38           DANAHER CORPORATION: COMPANY SNAPSHOT (2019)               169

12.4.2    KONINKLIJKE PHILIPS     173

FIGURE 39           KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2019)        173

12.4.3    HAMAMATSU PHOTONICS          176

FIGURE 40           HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2019)             176

12.4.4    F. HOFFMANN-LA ROCHE LTD.   178

FIGURE 41           F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)      178

12.4.5    SECTRA AB          181

FIGURE 42           SECTRA AB: COMPANY SNAPSHOT (2019)             181

12.4.6    3DHISTECH          184

12.4.7    APOLLO ENTERPRISE IMAGING CORP.    186

12.4.8    XIFIN, INC.          187

12.4.9    HURON DIGITAL PATHOLOGY     188

12.4.10  VISIOPHARM     190

12.4.11  CORISTA              192

12.4.12  INDICA LABS      193

12.4.13  OBJECTIVE PATHOLOGY SERVICES            194

 

12.4.14  OPTRASCAN, INC.            195

12.4.15  GLENCOE SOFTWARE, INC.          197

12.4.16  PAIGE   198

*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

12.5        OTHER COMPANIES        199

12.5.1    PATHAI 199

12.5.2    KONFOONG BIOTECH INTERNATIONAL CO., LTD.              199

12.5.3    INSPIRATA, INC.               200

12.5.4    MIKROSCAN TECHNOLOGIES, INC.           200

12.5.5    PROSCIA, INC.   200

12.5.6    KANTERON SYSTEMS      201

13           APPENDIX           202

13.1        DISCUSSION GUIDE        202

13.2        KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL   207

13.3        AVAILABLE CUSTOMIZATIONS   209

13.4        RELATED REPORTS           209

13.5        AUTHOR DETAILS             210

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127